There are great people there, but remember, they work for YOUR politicians and under normal circumstances the only way for the CDC professional staff to lose their jobs is to make anyone mad or sad, or both.
Every time they give a press conference, there's a politician behind a curtain waiting to stab them in the back - until that politician emerges two weeks later to say they didn't do enough.
My theory is there are subversives in the CDC just like their were in FBI who are on a mission to take down President Trump. I could be way off base and I am trying to come to terms with the idea that is it incompetence and not malice, but I don’t know. They started fixing some things literally overnight when VP Pence got involved. Reminds me of the pallets of PR aide sitting in warehouses, to make the President look bad.
I think they may have had the idea of letting it spread “a little”, enough to hurt the stick markets but that genie is out of the bottle, and it’s way more virulent than they expected.
To make matters worse, WHO has close ties to China and communism. I believe nothing they say. They refused to let our doctors and scientists go with their team to China and they have gushed with praise over China.
China has not release genetic sequences since sometime in January. Scientists study that sort of thing to determine origin, R0 and variations. So scientists are about 2-3 weeks trying to build the same out of outbreaks outside China.
Anyway, just a little theorizing and venting this morning with my coffee.
I’m glad that the President has added the scientist and doctors to the task force. We need more non CDC people looking at the data.
https://en.yna.co.kr/view/AEN20200303010900320
“Gilead’s remdesivir to be used to treat coronavirus patients in S. Korea
All Headlines 17:51 March 03, 2020
SHARE LIKE SAVE PRINT FONT SIZE
SEOUL, March 3 (Yonhap) — Glead Sciences’ experimental antiviral drug remdesivir is expected to be used to treat patients infected with the novel coronavirus in South Korea as part of a trial, drug industry sources said Tuesday.
Remdesivir, an investigational medication developed by U.S. pharmaceutical giant Gilead Sciences Inc., was previously tested against the Ebola virus. The drug has shown efficacy in COVID-19 patients in other countries on a trial basis as there is no specific treatment.
The sources said Gilead Sciences has been granted approval from local drug authorities to begin phase-three clinical trials of remdesivir for the treatment of COVID-19 in adult patients.
The approval by the Ministry of Food and Drug Safety came only four days after the application.
“Experimental drugs under clinical trial are sometimes granted approval for usage in cases where diseases are life-threatening and there is no other treatment option,” a ministry official said on condition of anonymity.
Remdesivir, currently under clinical trials in several countries, such as China, the epicenter of the outbreak, the United States and Japan, has not been fully approved by any country.
The ministry also allowed a locally-developed antiviral drug called Virus Suppressing Factor (VSF) to treat COVID-19 patients at the request of Seoul National University Hospital.
COVID-19 patients will be administered with a therapy called HzVSFv13, an injection-type of VSF developed by mid-sized bio firm ImmuneMed.
So far, most COVID-19 patients have been given treatments to relieve their symptoms while severe patients were given a combination of flu medicine and Kaletra, an anti-retroviral medication that was developed by global pharmaceutical firm AbbVie Inc. and is used to treat HIV.”